The present invention relates to a process for obtaining an inorganic nanostructured complex (cfi-1), protein-associated nanostructured complex (mrb-cfi-1) and antitumor use. The main application is in the treatment of urinary bladder cancer in both animals and humans. The complex has unique antitumor activity and can potentially be a substitute for other commercial antineoplastic drugs.
展开▼